tradingkey.logo

Biogen Sees 2026 Adj EPS $15.25 - $16.25 Versus IBES Estimate $14.92

ReutersFeb 6, 2026 11:26 AM

- Biogen Inc BIIB.O:

  • BIOGEN OUTLOOK 2026 ADJUSTED EPS $15.25 - $16.25 VERSUS IBES ESTIMATE $14.92

  • BIOGEN:SEES 2026 REVENUE TO DECLINE BY MID-SINGLE DIGIT PERCENTAGE VERSUS 2025

  • BIOGEN Q4 ADJUSTED EPS $1.99 VERSUS IBES ESTIMATE $1.59

  • BIOGEN Q4 REVENUE $2.28 BILLION VERSUS IBES ESTIMATE $2.20 BILLION

  • BIOGEN: Q4 LEQEMBI GLOBAL IN-MARKET SALES OF ABOUT $134 MILLION

  • FY2026 REVENUE VIEW $9.32 BILLION -- LSEG IBES DATA

Further company coverage: BIIB.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI